BridgeBio is significantly boosted the progress of the innovative treatment for amyloid heart disease, utilizing the investigational drug. Initial patient results suggests promising outcomes for individuals affected by https://attr-cm073662.pages10.com/company-progresses-cardiac-amyloidosis-therapy-through-the-drug-77585497